Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
A systematic scoping review of the neurological effects of COVID-19
Helena T. Hogberg
, Katya Tsaioun
, Joshua D. Breidenbach
, Bekki Elmore
, Julija Filipovska
, Natalia Garcia-Reyero
, Alan J. Hargreaves
, Ojasi Joshi
, Elma Omeragic
, Shannon Plant
, Rebecca Ram
, Ishita Virmani
, Jennifer Waspe
, Donna S. Macmillan
Bloomberg School of Public Health
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A systematic scoping review of the neurological effects of COVID-19'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
100%
Neurologic Disease
100%
Adverse Outcome Pathway
100%
SARS Coronavirus
100%
Observational Study
50%
Infection
50%
Multiple Sclerosis
50%
Nerve Degeneration
50%
Encephalitis
50%
Demyelination
50%
Coronavirinae
50%
Anosmia
50%
Pathogenesis
50%
Neuroscience
SARS Coronavirus
100%
Adverse Outcome Pathway
100%
Multiple Sclerosis
50%
Neurodegeneration
50%
Encephalitis
50%
Cognitive Effect
50%
Anosmia
50%
Coronavirinae
50%
Coronavirus
50%
Systematic Review
50%
Keyphrases
Neurological Effects
100%
Systematic Scoping Review
100%
COVID-19
100%
Exclusion Criteria
27%
Adverse Outcomes
18%
Neurological Symptoms
18%
Modulating Factors
18%
Adverse Outcome Pathway
18%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
18%
Multiple Sclerosis
9%
Neurodegeneration
9%
Cognitive Effects
9%
Demyelination
9%
Knowledge Gaps
9%
Biological Mechanisms
9%
Methodological Issues
9%
Encephalitis
9%
Over 75
9%
Anosmia
9%
Event Outcomes
9%
Knowledge Synthesis
9%
Abstract Screening
9%
Human Observational Studies
9%
Scoping Review
9%
Relevant Keywords
9%
Reporting Issues
9%
Medicine and Dentistry
COVID-19
100%
Scoping Review
100%
Adverse Outcome
40%
Neurologic Disease
20%
Severe Acute Respiratory Syndrome Coronavirus 2
20%
Observational Study
10%
Infection
10%
Multiple Sclerosis
10%
Neurodegeneration
10%
Systematic Review
10%
Encephalitis
10%
Demyelination
10%
Cognitive Effect
10%
Anosmia
10%
Coronavirinae
10%
Exclusion Criterion
10%
Pathogenesis
10%
Knowledge Gap
10%